Professor Hendrik Streeck is the Director of the Institute of Virology and Professor of HIV Research at the University of Bonn, Germany. He completed his medical training in Berlin in 2006 and received his PhD from Friedrich-Wilhelm University in Bonn in 2007. After completing his postdoctoral fellowship at the Partners AIDS Research Center, he was Assistant Professor at the Ragon Institute of MGH, MIT and Harvard and assistant immunologist at the Massachusetts General Hospital. In 2012, he was recruited as the Chief of the Cellular Immunology Section of the U.S. Military HIV Research Program and adjunct Assistant Professor of Emerging Infectious Diseases at the Uniformed Services University of the Health Sciences. In March 2015, he took the chair of the Institute for HIV Research, but remains visiting scientist at the Military HIV Research Program on HIV vaccine and cure research. Currently, he leads the largest systematic study to understand the feasibility of conducting a Phase 3 HIV vaccine trial in Europe and to understand the epidemic of sexually transmitted infections. As a result of the study, the European HIV & STI prevention network was established in January 2019.

Renzo Guinto, MD, DrPH, is one of the staunchest voices for the new field of planetary health. Renzo is the Chief Planetary Doctor of PH Lab, a “glo-cal think-and-do tank” for advancing the health of both people and the planet. He is also Associate Professor of the Practice of Global Public Health and Inaugural Director of the Planetary and Global Health Program of the St. Luke’s Medical Center College of Medicine in the Philippines.

Renzo is an Obama Foundation Asia-Pacific Leader, Aspen Institute New Voices Fellow and Climate Reality Leader (under the initiative of former US Vice President Al Gore). He is a member of several high-level groups, including: Lancet–Chatham House Commission on Improving Population Health post COVID-19 (University of Cambridge); Lancet One Health Commission (University of Oslo); Advisory Council of Global Health 50/50 (University College London); Advisory Board of Climate Cares (Imperial College London); Editorial Advisory Board of The Lancet Planetary Health; and Forum on Climate Change and Health of the World Innovation Summit for Health (Qatar Foundation). He has served as consultant for various organizations, including: World Health Organization; World Bank; USAID; International Organization for Migration; Health Care Without Harm; Philippine Department of Health; Chilean Ministry of Health; and Institute of Tropical Medicine in Antwerp, Belgium.

Renzo obtained his Doctor of Public Health from Harvard University and Doctor of Medicine from the University of the Philippines Manila. In 2020, Tatler Magazine included him in its Gen.T List of 400 leaders of tomorrow who are shaping Asia’s future. He has lectured in nearly 50 countries and published more than 100 articles in scientific journals, books and popular media; he has also directed and produced short films that communicate the message of planetary healing.

Professor Jenny Hoy is an infectious diseases physician and Professor Director of HIV Medicine at Alfred Health and Monash University. She graduated from Monash University and trained in infectious diseases at Fairfield Infectious Diseases in Melbourne, Australia. She led the HIV clinical research effort at Fairfield Hospital, participating in the evaluation of new antiretrovirals and new approaches to opportunistic infection prevention and management. The HIV service moved from Fairfield Hospital to Alfred Hospital in 1996 when Fairfield Hospital closed. Over the next 25 years, Professor Hoy has remained involved in care of people living with HIV and research, particularly research to aid the understanding of the pathogenesis, prevention and management of co-morbidities associated with ageing and HIV. She is actively engaged in HIV education for undergraduate, infectious diseases trainees and general practitioners. She has published widely, with over 300 publications, monographs and book chapters. She was a member of the Australian Antiretroviral Guidelines Panel for 22 years before joining the IAS-USA Antiretroviral Guidelines panel in 2012. Professor Hoy is passionate about ensuring quality of care for people with HIV and quality of life experienced by people with HIV.

Lynn Morris is a scientist who heads the HIV Virology section at the National Institute for Communicable Diseases (NICD) in Johannesburg, South Africa. She holds a joint appointment at the University of the Witwatersrand, where she is Research Professor and Director of the Antibody Immunity Research Unit. Over the past 20 years, she has made significant contributions to understanding the antibody response to HIV. With collaborators from Centre for the AIDS Programme of Research in South Africa (CAPRISA) and the National Institutes of Health (NIH) Vaccine Research Centre, she discovered the CAP256-VRC26.25 monoclonal antibody that is undergoing clinical testing. Her laboratory is responsible for conducting neutralizing antibody assays for HIV clinical trials, including the Antibody Mediated Prevention (AMP) trial, providing the proof of principle that VRC01 can prevent HIV infection. Lynn has been recognized through several awards. She has published over 270 papers, holds a current author H-Index of 61 and has featured in the Web of Science list of most highly cited researchers in 2015-2019.

Phelister Abdalla is the National Coordinator of the Kenya Sex Workers Alliance. She is a co-founder of the African Sex Workers Alliance (ASWA) and a pioneer of sex workers’ movements in Africa. She is on the front line of creating awareness and advocating for the rights of sex workers at national, regional and global levels; this includes lobbying and advocating for policy reform and leading the process of decriminalization of sex work in Kenya. She is known for her articulation in addressing critical issues, such as stigma and discrimination, violence faced by sex workers, empowerment of the community of sex workers, inclusion of the sex workers’ agenda across the country and Africa, and meaningfully involving communities in all aspects of programming and implementation.

Dr Stephane Wen-Wei Ku completed his medical degree at National Taiwan University in 2008 and specialist training in internal medicine and infectious diseases at Taipei Veterans General Hospital in 2013. He is currently working as the Director of the Division of Infectious Diseases at Taipei City Hospital Renai Branch and clinical researcher with the TREAT Asia Network at Taipei Veterans General Hospital. Dr Ku’s research interests include HIV and sexually transmitted infections, chemsex and sexual well-being of the LGBT community. He has been actively involved in PrEP implementation in Taiwan. Dr Ku serves as a council member of the Taiwan AIDS Society and Chairman of HIV Education And Research Taiwan.